Document Type : Original Article
Authors
- . Zahra Namjou 1
- . Seyed Ali Jafari 2
- . Aramesh Rezaeian 3
- . Majid Ghayour-Mobarhan 4
- . Samira Nasrfard 5
1 MSc in Pediatric Nursing, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran Department of Pediatrics, School of Nursing and Midwifery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 Associate Professor of Pediatric Gastroenterology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3 Evidence Based Care Research Center, Instructor Pediatric Nursing, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran, Department of Pediatrics, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran
4 Metabolic Syndrome Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, International UNESCO Center for Health Related Basic Sciences and Human Nutrition, Department of Nutrition, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
5 Graduate of Nutrition, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract
BACKGROUND: Chronic liver disease (CLD) is one of the most common chronic diseases in the
world that threatens the health of children due to its many complications such as malnutrition and
problems related to growth and development. Paying attention to nutrition and lifestyle modification
in these children is of special importance. Therefore, the aim of this study was to determine the effect
of nutritional education program on micronutrient intake in children with CLD.
MATERIALS AND METHODS: The present study is a two‑group randomized clinical trial that was
performed by available sampling and referred to Ghaem Children’s Hospital in Mashhad in 2016. In
this study, 77 children with CLD who met the inclusion criteria (45 children in the intervention group and
32 children in the control group) were studied. The intervention included six workshops and training on
proper diet, post‑workshop phone calls, and regular face‑to‑face counseling sessions (first 4 weeks
once a week and second 4 weeks once every 2 weeks) on adherence to the above diet. Patients
in the control group received routine care. The collection tools in the study included demographic
information questionnaires, body composition device, and diet plan form in the form of 24‑h recall
forms. Data analysis was performed using descriptive statistical tests and Mann–Whitney and
Wilcoxon statistical tests using SPSS software version 16.
RESULTS: Based on the results of the study, the mean age of the research units was 7.8 ± 3.6 years.
The mean duration of CLD was 4.6 ± 1.8 years in the intervention group and 5.1 ± 1.9 years in the
control group. The mean crude intake of most minerals after the intervention was significantly higher
than before the intervention, except for the crude intake of retinol, thiamine, riboflavin, folate, Vitamin
C, iodine, and Vitamin B12. Furthermore, in relation to the modified intake of micronutrients, the
mean modified intake of most micronutrients after the intervention showed a significant increase
compared to before, except for retinol, Vitamin D, niacin, B12, and iodine.
CONCLUSION: Considering the effect of providing a nutritional education program to improve
micronutrient intake in children with CLD and emphasizing the importance of adequate micronutrient
intake in improving the health of children, special nutrition programs should be provided to these
children with special attention. In this regard, nurses can play an important role in improving the
quality of nutrition of children by providing nutrition programs with appropriate follow‑up.
Keywords
InSeminars in liver disease 2005 Feb (Vol. 25, No. S 1, pp. 3‑8).
Published in 2005 by Thieme Medical Publishers, Inc., 333 Seventh
Avenue, New York, NY 10001, USA.
2. Zarei AR, Jahanpour F, Alhani F, Razazan N, Ostovar A. The
impact of multimedia education on knowledge and self‑efficacy
among parents of children with asthma: A randomized clinical
trial. J Caring Sci 2014;3:185‑92.
3. Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH,
Stanaway J, et al. Liver cirrhosis mortality in 187 countries between
1980 and 2010: A systematic analysis. BMC Med 2014;12:145.
4. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver
cancer in the United States, 1999‑2016: Observational study. BMJ
2018;362:k2817.
5. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR.
Underestimation of liver‑related mortality in the United States.
Gastroenterology 2013;145:375‑82.e2.
6. GBD 2017 Disease and Injury Incidence and Prevalence
Collaborators. Global, regional, and national incidence,
prevalence, and years lived with disability for 354 diseases and
injuries for 195 countries and territories, 1990‑2017: A systematic
analysis for the Global Burden of Disease Study 2017. Lancet
2018;392:1789‑858.
7. Marcdante K, Kliegman RM, Behrman RE. Nelson Essentials of
Pediatrics Elsevier, Philadelphia Health Sciences; 2010.
8. VanEdi LB. Prevalence of deppression in patients with COPD:
A systemic review. Thorax 1999;54:688‑92.
9. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C,
et al. Factors associated with poor health‑related quality of life of
patients with cirrhosis. Gastroenterology 2001;120:170‑8.
10. Borgaonkar MR, Irvine EJ. Quality of life measurement in
gastrointestinal and liver disorders. Gut 2000;47:444‑54.
11. Gulati R, Radhakrishnan KR, Hupertz V, Wyllie R, Alkhouri N,
Worley S, et al. Health‑related quality of life in children with
autoimmune liver disease. J Pediatr Gastroenterol Nutr
2013;57:444‑50.
12. Nightingale S, Ng VL. Optimizing nutritional management
in children with chronic liver disease. Pediatr Clin North Am
2009;56:1161‑83.
13. Kiani‑Sheikhabadi M, Beigi M, Mohebbi‑Dehnavi Z. The
relationship between perfectionism and body image with eating
disorder in pregnancy. J Educ Health Promot 2019;8:242.
14. Novy MA, Schwarz KB. Nutritional considerations and
management of the child with liver disease. Nutrition
1997;13:177‑84.
15. Fauci AS. Harrison’s Principles of Internal Medicine. New York:
McGraw‑Hill Medical; 2008.
16. Mouzaki M, Bronsky J, Gupte G, Hojsak I, Jahnel J, Pai N,
et al. Nutrition support of children with chronic liver diseases:
A joint position paper of the north american society for pediatric
gastroenterology, hepatology, and nutrition and the european
society for pediatric gastroenterology, hepatology, and nutrition.
J Pediatr Gastroenterol Nutr 2019;69:498‑511.
17. LautzHU, SelbergO, Körber J, Bürger M, Müller MJ. Protein‑calorie
malnutrition in liver cirrhosis. Clin Investig 1992;70:478‑86.
18. Kelishadi R, Farajian S, Mirlohi M. Probiotics as a novel treatment
for non‑alcoholic Fatty liver disease; a systematic review on the
current evidences. Hepat Mon 2013;13:e7233.
19. Bate KL, Jerums G. 3: Preventing complications of diabetes. Med
J Aust 2003;179:498‑503.
20. Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV. Self‑monitoring of blood glucose: Language and financial barriers
in a managed care population with diabetes. Diabetes Care
2000;23:477‑83.
21. RanjbaranS, ShojaeizadehD, DehdariT, YaseriM, ShakibazadehE.
Using health action process approach to determine diet adherence
among patients with Type 2 diabetes. J Educ Health Promot
2020;9:170.
22. Tehrani M, Baji Z, Shakerinejad G, Hajinajaf S, Jarvandi F,
Saki M. Effects of nutrition education on anthropometric
indices, biochemical and sonographic findings of patients with
Non‑alcoholic Fatty Liver Disease (NAFLD). Iran J Health Educ
Health Promot 2017;5:33‑42.
23. Amani R, Soflaei M. Nutrition education alone improves dietary
practices but not hematologic indices of adolescent girls in Iran.
Food Nutr Bull 2006;27:260‑4.
24. Dudek SG. Nutrition Essentials for Nursing Practice. United
States, Philadelphia Lippincott Williams & Wilkins, Apr 22. ; 2013.
25. Grønkjær LL, Wernberg C, Lauridsen MM. Non‑alcoholic
fatty liver disease: The role of the nurse. Gastrointest Nurs
2020;18 Suppl 6:S15‑21.
26. Asadi L, Amiri F, Safinejad H. Investigating the effect of health
literacy level on improving the quality of care during pregnancy
in pregnant women covered by health centers. J Educ Health
Promot 2020;9:286.
27. Sabaté E. Adherence to Long‑Term Therapies: Evidence for
ActionWHO World Health Organization; 2003.
28. Zandi M, Adib‑Hajbagheri M, Memarian R, Nejhad AK,
Alavian SM. Effects of a self‑care program on quality of life of
cirrhotic patients referring to Tehran Hepatitis Center. Health
Qual Life Outcomes 2005;3:35.
29. Flisiak‑Jackiewicz M, Lebensztejn DM. Update on pathogenesis,
diagnostics and therapy of nonalcoholic fatty liver disease in
children. Clin Exp Hepatol 2019;5:11‑21.
30. Africa JA, Newton KP, Schwimmer JB. Lifestyle interventions
including nutrition, exercise, and supplements for nonalcoholic
fatty liver disease in children. Dig Dis Sci 2016;61:1375‑86.
31. Pickett‑Blakely O, Young K, Carr RM. Micronutrients in
nonalcoholic fatty liver disease pathogenesis. Cell Mol
Gastroenterol Hepatol 2018;6:451‑62.
32. Vranešić Bender D, Nutrizio M, Jošić M, Ljubas Kelečić D, Karas I,
Premužić M, et al. Nutritional status and nutrition quality in
patients with non‑alcoholic fatty liver disease. Acta Clin Croat
2017;56:625‑34.
33. Shiota G. Loss of function of retinoic acid in liver leads to
steatohepatitis and liver tumor: A NASH animal model. Hepatol
Res 2005;33:155‑60.
34. Gavaravarapu SM, Konapur A, Saha S. Role of education and
communication interventions in promoting micronutrient
status in India – What research in the last two decades informs.
J Commun Healthc 2017;10:238‑49.
35. Chaves GV, Peres WA, Gonçalves JC, Ramalho A. Vitamin A and
retinol‑binding protein deficiency among chronic liver disease
patients. Nutrition 2015;31:664‑8.
36. Argao EA, Specker BL, Heubi JE. Bone mineral content in infants
and children with chronic cholestatic liver disease. Pediatrics
1993;91:1151‑4.
37. Leerbeck E, Søndergaard H. The total content of vitamin D in
human milk and cow’s milk. Br J Nutr 1980;44:7‑12.
38. Ojeda‑Rodríguez A, Zazpe I, Morell‑Azanza L, Chueca MJ,
Azcona‑Sanjulian MC, Marti A. Improved diet quality and
nutrient adequacy in children and adolescents with abdominal
obesity after a lifestyle intervention. Nutrients 2018;10:1500.
39. Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS.
Therapeutic role of niacin in the prevention and regression of
hepatic steatosis in rat model of nonalcoholic fatty liver disease.
Am J Physiol Gastrointest Liver Physiol 2014;306:G320‑7.
40. Vos MB, Colvin R, Belt P, Molleston JP, Murray KF, Rosenthal P,
et al. Correlation of vitamin E, uric acid, and diet composition with
histologic features of pediatric NAFLD. J Pediatr Gastroenterol
Nutr 2012;54:90‑6.
41. Da Silva HE, Arendt BM, Noureldin SA, Therapondos G,
Guindi M, Allard JP. A cross‑sectional study assessing
dietary intake and physical activity in Canadian patients with
nonalcoholic fatty liver disease vs healthy controls. J Acad Nutr
Diet 2014;114:1181‑94.
42. Kang X, Zhong W, Liu J, Song Z, McClain CJ, Kang YJ, et al. Zinc
supplementation reverses alcohol-induced steatosis in mice
through reactivating hepatocyte nuclear factor-4α and peroxisome
proliferator-activated receptor-α. Hepatology 2009;50:1241‑50.
43. AignerE, StrasserM, Haufe H, SonnweberT, HohlaF, StadlmayrA,
et al. A role for low hepatic copper concentrations in nonalcoholic
Fatty liver disease. Am J Gastroenterol 2010;105:1978‑85.
44. Nobili V, Siotto M, Bedogni G, Ravà L, Pietrobattista A, Panera N,
et al. Levels of serum ceruloplasmin associate with pediatric
nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr
2013;56:370‑5.
45. Antonucci L, Porcu C, Iannucci G, Balsano C, Barbaro B.
Non‑alcoholic fatty liver disease and nutritional implications:
Special focus on copper. Nutrients 2017;9:1137.
46. Rao S. Potential of community based approach for prevention
of anaemia among women of childbearing age from rural India.
J Food Nutr Sci 2014;2:270‑6.
47. Kumar MV, Nirmalan PK, Erhardt JG, Rahmathullah L,
Rajagopalan S. An efficacy study on alleviating micronutrient
deficiencies through a multiple micronutrient fortified salt in
children in South India. Asia Pac J Clin Nutr 2014;23:413‑22.
48. Hannah WN Jr., Harrison SA. Lifestyle and dietary interventions
in the management of nonalcoholic fatty liver disease. Dig Dis Sci
2016;61:1365‑74.
49. PapamiltiadousES, Roberts SK, NicollAJ, RyanMC, Itsiopoulos C,
Salim A, et al. A randomised controlled trial of a Mediterranean
Dietary Intervention for Adults with Non Alcoholic Fatty
Liver Disease (MEDINA): Study protocol. BMC Gastroenterol
2016;16:14.
50. Yang CH, Perumpail BJ, Yoo ER, Ahmed A, Kerner JA Jr.
Nutritional needs and support for children with chronic liver
disease. Nutrients 2017;9:1127.
51. Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ,
Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and
physical activity for patients with end-stage liver disease:
Improving functional status and sarcopenia while on the
transplant waiting list. Liver Transplant 2018;24:122‑39.
52. Pfirrmann D, Huber Y, Schattenberg JM, Simon P. Web‑based
exercise as an effective complementary treatment for patients
with nonalcoholic fatty liver disease: Intervention study. J Med
Internet Res 2019;21:e11250.
53. Hefner AM, Barakat F, Hall K, Pozza R, Hill C, Hassanein T,
editors. Integrating Nurses in the Management and Care of
Patients with NAFLD: Better Adherence and Outcomes. 1000AE
Amsterdam, Netherlands: Elsevier Science BV PO Box 211; 2019.
54. Motamedrezaei O, Moodi M, Miri MR, Khodadadi M. The effect
of nutrition and food hygieneeducation on the knowledge of
female elementary school teachers in city of ferdows. J Educ
Health Promot 2013;2:10.
55. Kalani Z, Pourkermanian P, Alimohammadi N. The effect of
family guided visits on the level of consciousness in traumatic
brain injury. J Biol Todays World 2016;5:86‑90.
56. Gholami M, Moallem SA, Afshar M, Etemad L, Karimi G.
Gestational exposure to silymarin increases susceptibility of
BALB/c mice fetuses to apoptosis. Avicenna J Med Biotechnol
2017;9:66‑70.
57. Gholami M, Moallem SA Afshar M, Etemad L, Karimi G. Maternal
exposure to silymarin leads to phatological changes in mouse
foetuses. Pharmacologyonline 2015;2:38‑43.
)